Last updated on June 2019

Study to Evaluate CCS1477 in Advanced Tumours

Brief description of study

A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 in patients with metastatic castration resistant prostate cancer (mCRPC) or advanced solid tumours.

Clinical Study Identifier: NCT03568656

Find a site near you

Start Over

Freeman Hospital

Newcastle, United Kingdom
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.